scholarly journals The impact of third-generation Beta-blocker antihypertensive treatment on endothelial function and the prothrombotic stateEffects of smoking

2004 ◽  
Vol 17 (7) ◽  
pp. 582-589 ◽  
Author(s):  
G VYSSOULIS
Keyword(s):  
Endothelial Function ◽  
Beta Blocker ◽  
Antihypertensive Treatment ◽  
Third Generation ◽  
The Impact

scholarly journals Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Thomas Duflot ◽  
Charlotte Laurent ◽  
Anne Soudey ◽  
Xavier Fonrose ◽  
Mouad Hamzaoui ◽  
...  
Keyword(s):  
Endothelial Function ◽  
Kidney Transplant ◽  
Plasma Levels ◽  
Renal Allograft ◽  
Transplant Recipients ◽  
Loss Of Function ◽  
Kidney Transplant Recipients ◽  
Allograft Dysfunction ◽  
Allograft Function ◽  
The Impact

AbstractThis study addressed the hypothesis that epoxyeicosatrienoic acids (EETs) synthesized by CYP450 and catabolized by soluble epoxide hydrolase (sEH) are involved in the maintenance of renal allograft function, either directly or through modulation of cardiovascular function. The impact of single nucleotide polymorphisms (SNPs) in the sEH gene EPHX2 and CYP450 on renal and vascular function, plasma levels of EETs and peripheral blood monuclear cell sEH activity was assessed in 79 kidney transplant recipients explored at least one year after transplantation. Additional experiments in a mouse model mimicking the ischemia–reperfusion (I/R) injury suffered by the transplanted kidney evaluated the cardiovascular and renal effects of the sEH inhibitor t-AUCB administered in drinking water (10 mg/l) during 28 days after surgery. There was a long-term protective effect of the sEH SNP rs6558004, which increased EET plasma levels, on renal allograft function and a deleterious effect of K55R, which increased sEH activity. Surprisingly, the loss-of-function CYP2C9*3 was associated with a better renal function without affecting EET levels. R287Q SNP, which decreased sEH activity, was protective against vascular dysfunction while CYP2C8*3 and 2C9*2 loss-of-function SNP, altered endothelial function by reducing flow-induced EET release. In I/R mice, sEH inhibition reduced kidney lesions, prevented cardiac fibrosis and dysfunction as well as preserved endothelial function. The preservation of EET bioavailability may prevent allograft dysfunction and improve cardiovascular disease in kidney transplant recipients. Inhibition of sEH appears thus as a novel therapeutic option but its impact on other epoxyfatty acids should be carefully evaluated.

Evaluation of the Impact of Treatment on Endothelial Function and Cardiac Performance in Acromegaly

2010 ◽  
Vol 27 (8) ◽  
pp. 990-996 ◽  
Author(s):  
Ebru Akgul ◽  
S. Lale Tokgozoglu ◽  
Tomris Erbas ◽  
Giray Kabakci ◽  
Kudret Aytemir ◽  
...  
Keyword(s):  
Endothelial Function ◽  
Cardiac Performance ◽  
The Impact

The impact of obstructive sleep apnea on endothelial function during weight loss in an obese pediatric population

2021 ◽  
Author(s):  
Sofie Jacobs ◽  
Emilie Mylemans ◽  
Marijke Ysebaert ◽  
Eline Vermeiren ◽  
Ann De Guchtenaere ◽  
...  
Keyword(s):  
Weight Loss ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Endothelial Function ◽  
Pediatric Population ◽  
Obstructive Sleep ◽  
The Impact

Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits

2003 ◽  
Vol 104 (4) ◽  
pp. 357-365 ◽  
Author(s):  
Natalia de las HERAS ◽  
Eva CEDIEL ◽  
M. Pilar OUBIÑA ◽  
Paloma ARAGONCILLO ◽  
David SANZ-ROSA ◽  
...  
Keyword(s):  
Endothelial Function ◽  
Receptor Antagonist ◽  
Plasminogen Activator ◽  
Vascular Function ◽  
Harmful Effect ◽  
Tissue Type ◽  
Vascular Structure ◽  
Similar Increase ◽  
The Impact ◽  
Pai 1

We compared the impact of hypercholesterolaemia and mixed dyslipidaemia on vascular function, vascular structure and fibrinolytic balance in rabbits. To this end, vascular reactivity was studied in aortic rings from rabbits fed a control diet, a diet containing 0.5% cholesterol+14% coconut oil (mixed dyslipidaemia) or a diet containing 1% cholesterol (hypercholesterolaemia) for 12–14 weeks. Morphometric analysis of aorta was also performed and plasminogen activator inhibitor-1 (PAI-1) as well as tissue-type plasminogen activator (t-PA) plasma activities were measured. Both diets induced a similar increase in cholesterol plasma levels, although triacylglycerols (triglycerides) were increased in animals with mixed dyslipidaemia. Hypercholesterolaemia was associated with intimal thickening, reduction in acetylcholine-induced relaxation (P<0.05) and increased vasoconstriction induced by acetylcholine+NG-nitro-L-arginine methyl ester (L-NAME) when compared with controls (P<0.05). These effects were more marked (P<0.05) in animals with mixed dyslipidaemia. Incubation with ifetroban, a thromboxane A2/prostaglandin H2 receptor antagonist, increased acetylcholine-induced relaxation (P<0.05) and reduced acetylcholine+L-NAME contraction (P<0.05) in both diet groups. In contrast, the presence of PD 145, an endothelin (ET)A/ETB receptor antagonist, exerted these effects only in rabbits with mixed dyslipidaemia. Both hypercholesterolaemia and mixed dyslipidaemia induced a similar increase in PAI-1 and a similar decrease in t-PA plasma activities. These data suggest that hypertriglyceridaemia can increase the deleterious effects of hypercholesterolaemia on endothelial function and vascular structure. This additional harmful effect exerted by triacylglycerols on endothelial function could, in part, be mediated by ET.

Facing Up to Moving Forward: A Third-Generation Successor's Reflections

1989 ◽  
Vol 2 (1) ◽  
pp. 17-29 ◽  
Author(s):  
Roderick W. Correll
Keyword(s):  
Family Business ◽  
Third Generation ◽  
Personal Statement ◽  
The Impact ◽  
Made In

The author describes his experience as the successor in a family business in a personal statement describing his struggle to differentiate from his family and define his own dream within the business. The impact of his developmental journey on decisions made in the business, and vice versa, is depicted in detail.

Effects of Antihypertensive Treatment on Endothelial Function

2011 ◽  
Vol 13 (4) ◽  
pp. 276-281 ◽  
Author(s):  
Agostino Virdis ◽  
Lorenzo Ghiadoni ◽  
Stefano Taddei
Keyword(s):  
Endothelial Function ◽  
Antihypertensive Treatment

Abstract 4688: The Impact of Marfan Syndrome on Arterial Stiffness and Endothelial Function: The Role of Matrix Metalloproteinases

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Stella Brilli ◽  
Dimitris Tousoulis ◽  
Charalambos Antoniades ◽  
George Hatzis ◽  
Nikos Ioakeimidis ◽  
...  
Keyword(s):  
Matrix Metalloproteinases ◽  
Arterial Stiffness ◽  
Endothelial Function ◽  
Marfan Syndrome ◽  
Augmentation Index ◽  
Flow Mediated Dilation ◽  
Arterial Tree ◽  
Augmentation Pressure ◽  
The Impact

Background: Marfan syndrome is characterised by high risk of aortic dissections and increased cardiovascular risk. However, the impact of Marfan syndrome on endothelial function and arterial stiffness is unclear, while the role of matrix metalloproteinases is unknown. We examined the impact of Marfan syndrome on the elastic properties of the arterial tree, and vascular endothelial function, and we evaluated the potential role of matrix metalloproteinases in these effects. Methods: The study population consisted of 17 subjects with Marfan syndrome, aged 26.6±2.3 years old, with BMI 20.5±1.03Kg/m2 and 22 healthy individuals matched for gender, age (26.4±0.78 years old, p=NS) and BMI (22.4±0.86 Kg/m2). Arterial stiffness was evaluated by measuring carotid-femoral pulse wave velocity (PWV), while augmentation pressure and augmentation index (AIx) were also determined, as measures of arterial wave reflections. Endothelial function was evaluated by determining flow mediated dilation (FMD) in the brachial artery while matrix metalloproteinase 9 (MMP-9) levels were determined by ELISA. Results: Patients with Marfan syndrome had significantly lower pulse pressure in the radial artery (41.0±1.07mmHg) compared to controls (51.3±4.4mmHg). In addition, patients had higher AIx (17.6±2.4%) and augmentation pressure (5.44±0.65mmHg) compared to controls (7.72±3.43% and 2.41±1.14mmHg respectively, p<0.05 for both). However, the difference in PWV between patients and controls did not reach statistical significance (6.33±0.33 vs 5.96±0.23m/s respectively, p=NS). Patients with Marfan syndrome had lower FMD (2.05±1.13%) and higher plasma MMP-9 (827±70ng/ml) compared to controls (6.8±2.3% p<0.05 and 326±50ng/ml, p<0.01). Conclusions: Marfan syndrome is associated with increased MMP-9 levels, as well as with elevated augmentation index and augmentation pressure compared to healthy individuals, matched for age, gender and body mass index. Moreover, flow-mediated dilation is also impaired in these subjects. These findings suggest that Marfan syndrome directly affects the elastic properties and endothelial function of the arterial tree, with matrix metalloproteinases being important mediators in the pathophysiology of this syndrome.

Sign in / Sign up

Export Citation Format

Share Document